Published in Lab Business Week, October 14th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Lonza Group.
Report 2: Lonza Group Ltd (SWX: LONN), the global life sciences company, announces that Lonza has granted UCB a non-exclusive, worldwide license to their GS Gene Expression SystemTM (GS: glutamine synthetase). The Research Evaluation Agreement covers the use of the GS Gene Expression SystemTM for research and development purposes.
An option to obtain a license to use the GS Gene Expression SystemTM for commercial purposes is...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.